Congenital Bleeding Disorder

Showing 1 - 25 of 84

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (Turoctocog alfa pegol)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • Turoctocog alfa pegol
  • Phoenix, Arizona
  • +66 more
Dec 20, 2022

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

Active, not recruiting
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa pegol
  • Phoenix, Arizona
  • +69 more
Mar 18, 2022

Congenital Bleeding Disorder, Haemophilia B Trial in Worldwide (nonacog beta pegol)

Active, not recruiting
  • Congenital Bleeding Disorder
  • Haemophilia B
  • nonacog beta pegol
  • Los Angeles, California
  • +63 more
Nov 30, 2021

Novoeight®/NovoEight® in Mexican Haemophilia A Patients

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Monterrey, Nuevo León, Mexico
    Novo Nordisk Investigational Site
Nov 12, 2021

NovoEight® During Long-term Treatment of Haemophilia A in Japan

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Suginami-ku, Tokyo, Japan
  • +1 more
Nov 12, 2021

Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors Trial in Worldwide (Concizumab,

Completed
  • Congenital Bleeding Disorder
  • +2 more
  • Los Angeles, California
  • +21 more
Sep 24, 2021

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Phoenix, Arizona
  • +68 more
Nov 26, 2020

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa pegol
  • Phoenix, Arizona
  • +92 more
Nov 3, 2020

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa pegol
  • Phoenix, Arizona
  • +50 more
Nov 3, 2020

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa pegol
  • Phoenix, Arizona
  • +69 more
Jul 27, 2020

Congenital Bleeding Disorder, Haemophilia A Trial in China (turoctocog alfa)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Beijing, Beijing, China
  • +10 more
Jul 24, 2020

Turoctocog Alfa During Long-Term Treatment of Severe and

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Mobile, Alabama
  • +40 more
Apr 24, 2020

Congenital Bleeding Disorder, Haemophilia A Trial in India (turoctocog alfa)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Bangalore, Karnataka, India
  • +9 more
Apr 16, 2020

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa pegol
  • Orlando, Florida
  • +18 more
Jan 31, 2020

Congenital Bleeding Disorder, Haemophilia B Trial in Germany, Switzerland, United States (N9-GP, ALPROLIX®)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia B
  • Phoenix, Arizona
  • +11 more
Nov 21, 2019

Congenital FXIII Deficiency,Prospective Multi-centre

Completed
  • Congenital Bleeding Disorder
  • Congenital FXIII Deficiency
  • Orange, California
  • +16 more
Jul 8, 2019

Congenital Bleeding Disorder, Haemophilia A, Healthy Trial in Worldwide (NNC172-2021)

Terminated
  • Congenital Bleeding Disorder
  • +2 more
  • Wien, Austria
  • +5 more
May 14, 2019

Congenital Bleeding Disorder, Haemophilia A, Haemophilia B Trial in Worldwide (NNC 0172-0000-2021, )

Completed
  • Congenital Bleeding Disorder
  • +3 more
  • NNC 0172-0000-2021
  • placebo
  • Wien, Austria
  • +15 more
May 14, 2019

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa
  • Chicago, Illinois
  • +14 more
Jan 29, 2019

Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors Trial in Worldwide (No treatment

Completed
  • Congenital Bleeding Disorder
  • +2 more
  • No treatment given
  • Tucson, Arizona
  • +14 more
Jul 10, 2018

Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors Trial in Worldwide (activated

Completed
  • Congenital Bleeding Disorder
  • +2 more
  • activated recombinant human factor VII, long acting
  • Little Rock, Arkansas
  • +24 more
Sep 3, 2018

Congenital Bleeding Disorder, Haemophilia B Trial in Worldwide (nonacog beta pegol)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia B
  • nonacog beta pegol
  • Los Angeles, California
  • +48 more
Apr 9, 2018

Congenital Bleeding Disorder, Congenital FXIII Deficiency Trial in Worldwide (catridecacog)

Completed
  • Congenital Bleeding Disorder
  • Congenital FXIII Deficiency
  • Orange, California
  • +33 more
Jan 18, 2018

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa pegol
  • Torrance, California
  • +13 more
Dec 14, 2017

Congenital Bleeding Disorder, Haemophilia B Trial in Worldwide (nonacog beta pegol)

Completed
  • Congenital Bleeding Disorder
  • Haemophilia B
  • nonacog beta pegol
  • Los Angeles, California
  • +40 more
Jul 24, 2017